Rocha A, Ruiz S, Tafalla C, Coll J M
Departamento di Biotecnología, SGIT, INIA, Madrid, Spain.
J Virol. 2004 Sep;78(17):9115-22. doi: 10.1128/JVI.78.17.9115-9122.2004.
Fourteen single and two double point mutants in the highly conserved region (positions 56 to 159) of the G gene of viral hemorrhagic septicaemia virus (VHSV), a salmonid rhabdovirus, were selected and obtained in plasmids by site-directed mutagenesis. Fish cell monolayers transfected with the mutant plasmids were then assayed for protein G (pG) expression, conformation-dependent monoclonal antibody (MAb) reactivity, and cell-cell fusion. Some mutations located in the phospholipid-binding p2 peptide (positions 82 to 110; mutants P86A, A96E, G98A, and R107A) abolished both MAb recognition and fusion activity, while others (P79A, L85S, and R103A) abolished MAb recognition but retained fusion at similar or lower pHs compared to those for the wild type. Phospholipid-binding assays of p2-derived synthetic peptides suggested that phosphatidylserine binding was not affected by the mutations studied. On the other hand, three (P79A, L85S, and T135E) of the four mutants retaining fusion activity mapped around two locations showing amino acid variation in 22 VHSV isolates and in neutralizing MAb-resistant mutants described previously. Mutations located in the hypothetical fusion peptide (positions 142 to 159; mutants F147K, P148K, and W154K) abolished both MAb recognition and fusion activity. The existence of mutants with altered conformation and defective fusion in both p2 and fusion peptides provides further evidence in favor of the participation of these and adjacent regions in some of the steps of the VHSV fusion processes, as suggested by previous studies. In addition, because the studied region induced strong immunological responses in trout, some of the mutants described here might be used to design attenuated VHSV vaccines.
选择了鲑鱼弹状病毒——病毒性出血性败血症病毒(VHSV)G基因高度保守区域(第56至159位)的14个单点突变体和2个双点突变体,并通过定点诱变在质粒中获得。然后对用突变体质粒转染的鱼细胞单层进行蛋白G(pG)表达、构象依赖性单克隆抗体(MAb)反应性和细胞-细胞融合检测。位于磷脂结合p2肽段(第82至110位;突变体P86A、A96E、G98A和R107A)的一些突变消除了MAb识别和融合活性,而其他突变(P79A、L85S和R103A)消除了MAb识别,但与野生型相比,在相似或更低pH值下保留了融合活性。p2衍生合成肽的磷脂结合试验表明,所研究的突变不影响磷脂酰丝氨酸结合。另一方面,保留融合活性的四个突变体中的三个(P79A、L85S和T135E)定位在两个位置周围,这两个位置在22个VHSV分离株以及先前描述的中和MAb抗性突变体中显示出氨基酸变异。位于假定融合肽段(第142至159位;突变体F147K、P148K和W154K)的突变消除了MAb识别和融合活性。如先前研究所暗示的,在p2和融合肽段中存在构象改变和融合缺陷的突变体,为这些区域和相邻区域参与VHSV融合过程的某些步骤提供了进一步证据。此外,由于所研究区域在鳟鱼中诱导了强烈的免疫反应,这里描述的一些突变体可能用于设计减毒VHSV疫苗。